Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
Hadley
Jason C
JC
Department of Dermatology, University of Utah, Salt Lake City, Utah 84123, USA. Jason.Hadley@hsc.utah.edu
Tristani-Firouzi
Payam
P
Florell
Scott F
SF
Bowen
Glen M
GM
Hadley
Michael L
ML
D017255:Acitretin / Q000008:administration & dosage; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005542:Forearm; D006801:Humans; D015552:Injections, Intralesional; D007636:Keratoacanthoma / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D007641:Keratolytic Agents / Q000009:adverse effects; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D012008:Recurrence; D012878:Skin Neoplasms / Q000209:etiology / Q000473:pathology* / Q000628:therapy
D000970:Antineoplastic Agents; D007641:Keratolytic Agents; D017255:Acitretin; D005472:Fluorouracil; D008727:Methotrexate